EX-1.1
from 8-K
44 pages
5,600,000 Shares of Common Stock Pre-Funded Warrants to Purchase 9,000,000 Shares of Common Stock Common Stock Warrants to Purchase 14,600,000 Shares of Common Stock BioXcel Therapeutics, Inc. Underwriting Agreement
12/34/56
EX-1.2
from S-3
43 pages
BioXcel Therapeutics, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.001 Per Share (The “Common Shares”), Having an Aggregate Offering Price of Up to the Maximum Program Amount (As Defined Herein) on the Terms Set Forth in This Agreement (This “Agreement”). Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings
12/34/56
EX-1.1
from 8-K
39 pages
BioXcel Therapeutics, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.001 Per Share (The “Common Shares”), Having an Aggregate Offering Price of Up to the Maximum Program Amount (As Defined Herein) on the Terms Set Forth in This Agreement (This “Agreement”). Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings
12/34/56
